Monte Rosa Therapeutics Inc (GLUE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 129,883 | 224,254 | 128,101 | 55,872 | 346,071 |
| Marketable Securities | 247,221 | 147,895 | 104,312 | 207,914 | N/A |
| Receivables | 11,600 | 173 | 505 | 7,656 | N/A |
| TOTAL | $393,185 | $377,440 | $236,212 | $275,886 | $348,666 |
| Non-Current Assets | |||||
| PPE Net | 25,986 | 29,483 | 33,803 | 27,075 | 12,325 |
| Other Non-Current Assets | 29,488 | 31,809 | 33,740 | 39,428 | 5,338 |
| TOTAL | $55,474 | $61,292 | $67,543 | $66,503 | $17,663 |
| Total Assets | $448,659 | $438,732 | $303,755 | $342,389 | $366,329 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,550 | 17,215 | 11,152 | 7,862 | 6,558 |
| Accrued Expenses | 26,694 | 18,785 | 14,600 | 14,580 | 10,080 |
| TOTAL | $64,212 | $156,946 | $46,592 | $25,569 | $16,638 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 29,571 | 117,232 | 17,678 | N/A | N/A |
| Other Non-Current Liabilities | 34,794 | 39,001 | 42,877 | 43,874 | 0 |
| TOTAL | $151,391 | $58,850 | $77,913 | $45,407 | $2,176 |
| Total Liabilities | $215,603 | $215,796 | $124,505 | $70,976 | $18,814 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 80,016 | 61,510 | 50,154 | 49,359 | 46,630 |
| Common Shares | 7 | 6 | 5 | 5 | 5 |
| Retained earnings | -477,214 | -438,588 | -365,888 | -230,536 | -122,035 |
| Other shareholders' equity | -3,827 | -3,356 | -2,724 | -1,752 | -2,021 |
| TOTAL | $233,056 | $222,936 | $179,250 | $271,413 | $347,515 |
| Total Liabilities And Equity | $448,659 | $438,732 | $303,755 | $342,389 | $366,329 |